The Smart Investor
    Facebook Instagram
    Sunday, July 26
    Facebook Instagram LinkedIn
    The Smart Investor
    • Home
    • About
      • About Us
      • Careers
    • Smart Investing
      • Getting Started
      • Investing Strategy
      • Smart Analysis
      • Smart Reads
    • US Stocks
    • Special Free Reports!
    • As Featured on BT
    • Our Services
      • Our Services
      • Subscribe now!
    • Login
    • Cart
    The Smart Investor
    Home»Smart Reads»Smart Reads of the Week: Singapore’s Best Bank, Keppel’s Higher Bid for SPH, and Pfizer’s COVID-19 Pill
    Smart Reads

    Smart Reads of the Week: Singapore’s Best Bank, Keppel’s Higher Bid for SPH, and Pfizer’s COVID-19 Pill

    We bring you a collection of articles on Singapore's banks and how Pfizer's new pill could provide a strong boost for the aviation and tourism sectors.
    The Smart InvestorBy The Smart InvestorNovember 13, 2021Updated:September 26, 20233 Mins Read
    Facebook Twitter LinkedIn Email WhatsApp
    The Smart Investor Smart Reads Pic 9
    Share
    Facebook Twitter LinkedIn Email WhatsApp

    Last week, the big three Singapore banks DBS Group (SGX: D05), United Overseas Bank Ltd (SGX: U11) and OCBC Ltd (SGX: O39) reported their fiscal 2021 third-quarter earnings.

    All three banks handily beat analysts’ expectations …

    …  but which of the three banks is the best to invest in right now?

    We help to compare all three banks and come to a conclusion based on operating and financial metrics.

    Meanwhile, in a surprise move, Keppel Corporation Limited (SGX: BN4) has raised its bid to acquire Singapore Press Holdings Limited (SGX: T39), or SPH, by 12%.

    We help to break down the announcement to see what the implications are for investors.

    Finally, there’s more good news in the fight against COVID-19.

    Pfizer (NYSE: PFE), the company that concocted a vaccine with around 95% efficacy, has devised a pill that can supposedly cut the risk of severe illness and hospitalisation by nearly 90%.

    If this pill is as good as claimed, it will help add to our arsenal of tools against the virus and accelerate the recovery of travel and tourism stocks.

    Here is a list of our top articles for the week.

    1. All 3 Singapore Banks Have Reported Stellar Results: Which Should You Pick Now?

    As mentioned above, we compare the results for all three banks to see which qualifies as the most enticing investment choice right now.

    2. Keppel Corporation Offers S$2.351 per share for SPH: Is A Bidding War Coming?

    With the announcement of Keppel Corporation’s higher offer, could this trigger a bidding war for SPH?

    3. Pfizer’s COVID-19 Pill Ignites Travel and Tourism Stocks: Here’s What Investors Should Watch

    Pfizer’s new COVID-19 pill offers hope to the travel and tourism industries. Here’s what investors need to look out for.

    4. 3 Growth Stocks That Will Take Your Portfolio to the Next Level

    Here are three growth stocks that can elevate your portfolio to a higher level.

    5. 3 Stocks with Dividend Yields of 5% or More

    Looking for stocks with sustainable dividend yields of 5% and above? Here are three that you can add to your watchlist.

    6. 3 Stocks That Are Perfect for Your SRS Account

    Don’t let your SRS funds sit idle in the account earning low interest. Here are three stocks you can invest in to improve your returns.

    7. Singtel More Than Doubles Its Net Profit to Nearly S$1 Billion: 5 Things You Need to Know

    Singtel (SGX: Z74) reported an encouraging set of financial numbers for its fiscal 2022 first half. Here are five things that investors need to know about its earnings.

    8. Lion-Phillip S-REIT ETF: 10 Must-Know Facts To Learn Before You Buy

    We take a look at the Lion-Phillip Singapore REIT ETF to sift out some details.

    9. CSOP iEdge S-REIT Leaders Index ETF: 10 Key Facts About The New ETF

    We delve into another ETF to bring you some facts on it before you decide to buy.

    10. Retirement and Re-employment Age Raised to 65 and 70 years: 4 Steps You Can Take

    With the retirement and re-employment age set to rise over the years, here are four steps you can take to cope with this new reality.

    Want to stay abreast of the latest investing news, analyses, and stories for FREE? Subscribe to our weekly email, Smart Reads, now to receive a curated list of our top articles weekly. CLICK HERE to subscribe now!

    Follow us on Facebook and Telegram for the latest investing news and analyses!

    Please refer to the individual articles for stock ownership disclosures.

    Share. Facebook Twitter LinkedIn Email WhatsApp

    Related Posts

    The Smart Investor Smart Reads Pic 6

    Smart Reads of the Week: Singapore Dividend Stocks, Blue-Chip Leaders, and Hidden SGX Opportunities

    July 19, 2026
    Smart Reads Pic 13

    Smart Reads of the Week: Bonus Dividends, Singapore AI Stocks, and Passive Income Ideas

    July 12, 2026
    The Smart Investor Smart Reads Pic 2

    Smart Reads of the Week: Blue-Chip Stocks, High-Yield REITs, and Singapore Market Opportunities

    July 5, 2026
    Facebook Instagram LinkedIn Telegram
    • Careers
    • Disclaimer & Privacy Policy
    • Advertising & Media Enquiries
    • Subscription Terms of Service
    © 2026 The Smart Investor. All Rights Reserved. The Smart Investor, thesmartinvestor.com.sg, an investment education website managed by The Investing Hustle Pte Ltd (Company Reg No. 201933459Z) is not licensed or otherwise regulated by the Monetary Authority of Singapore, and in particular, is not licensed or regulated to carry on business in providing any financial advisory service. Accordingly, any information provided on this site is meant purely for informational and investor educational purposes and should not be relied upon as financial advice. No information is presented with the intention to induce any reader to buy, sell, or hold a particular investment product or class of investment products. Rather, the information is presented for the purpose and intentions of educating readers on matters relating to financial literacy and investor education. Accordingly, any statement of opinion on this site is wholly generic and not tailored to take into account the personal needs and unique circumstances of any reader. The Smart Investor does not recommend any particular course of action in relation to any investment product or class of investment products. Readers are encouraged to exercise their own judgment and have regard to their own personal needs and circumstances before making any investment decision, and not rely on any statement of opinion that may be found on this site.

    Type above and press Enter to search. Press Esc to cancel.